Skip to content

ConMed

US · CNMD #3018 by market cap Listed 1970
44.23 -0.25 -0.56%
Live - 5344 symbols - heartbeat 146s ago · 2026-10-08 07:01
Pre-market 43.92 -0.69%
After-hours 44.23 0.00%
Overnight 44.24 +0.02%
Market cap
1.32B
P/B
1.27
EPS
1.51
Reader sentiment Are you bullish or bearish on CNMD?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Needham Maintains ConMed(CNMD.US) With Buy Rating, Cuts Target Price to $61
    Market Newswire · 2025/5/2
  • J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $40
    Market Newswire · 2026/7/13
  • Rating change
    Needham Downgrades ConMed(CNMD.US) to Hold Rating
    Market Newswire · 2025/6/13
  • Rating change
    Piper Sandler Maintains ConMed(CNMD.US) With Buy Rating, Cuts Target Price to $68
    Market Newswire · 2025/7/31
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Alto Neuroscience, Inc. (ANRO) and Pfizer (PFE)
    TipRanks · 2026/3/18
  • Rating change
    Needham Maintains ConMed(CNMD.US) With Hold Rating, Announces Target Price $35.96
    Market Newswire · 2026/4/30
  • A Quick Look at Today's Ratings for ConMed(CNMD.US), With a Forecast Between $45 to $46
    Market Newswire · 2026/7/31
  • Rating change
    Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (CGON) and Conmed (CNMD)
    TipRanks · 2025/12/6
  • Needham Maintains ConMed(CNMD.US) With Hold Rating
    Market Newswire · 2026/7/13
  • Rating change
    Piper Sandler Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/1/29
  • Rating change
    BofA Securities Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $52
    Market Newswire · 2025/12/8
  • Rating change
    J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $40
    Market Newswire · 2026/4/30
  • Rating change
    Piper Sandler Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $39
    Market Newswire · 2026/4/30
  • Rating change
    TR | OpenAI - 4o Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $60
    Market Newswire · 2025/8/12
  • Rating change
    J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $52
    Market Newswire · 2025/11/6
  • Rating change
    Piper Sandler Maintains ConMed(CNMD.US) With Buy Rating, Cuts Target Price to $55
    Market Newswire · 2025/11/6
  • Rating change
    Piper Sandler Downgrades ConMed(CNMD.US) to Hold Rating, Cuts Target Price to $39
    Market Newswire · 2026/3/17
  • BofA Securities Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $40
    Market Newswire · 2026/5/18
  • Rating change
    Wells Fargo Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $42
    Market Newswire · 2026/3/18

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:01:20 · For reference only, not investment advice and not tailored to your situation.